Author:
Seminotti Bianca,Latini Alexandra,Amaral Alexandre U.,Leipnitz Guilhian,Wajner Moacir
Publisher
Springer International Publishing
Reference50 articles.
1. Barić, I., Wagner, L., Feyh, P., Liesert, M., Buckel, W., & Hoffmann, G. F. (1999). Sensitivity and speciticity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. Journal of Inherited Metabolic Disease, 22, 867–882. https://doi.org/10.1023/A:1005683222187
2. Bennett, M. J., & Santani, A. B. (2016). Carnitine palmitoyltransferase 1A deficiency. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. Stephens, & A. Amemiya (Eds.), GeneReviews® [Internet] (pp. 1–15). University of Washington.
3. Bennett, M. J., Marlow, N., Pollitt, R. J., & Wales, J. K. H. (1986). Glutaric aciduria type 1: Biochemical investigations and postmortem findings. European Journal of Pediatrics, 145, 403–405. https://doi.org/10.1007/BF00439248
4. Bjugstad, K. B., Zawada, W. M., Goodman, S. I., & Freed, C. R. (2001). IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. Journal of Inherited Metabolic Disease, 24, 631–647. https://doi.org/10.1023/A:1012706908779
5. Burckhardt, G., & Burckhardt, B. C. (2011). In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. Handbook of Experimental Pharmacology, 201, 29–104. https://doi.org/10.1007/978-3-642-14541-4_2